Impact of HPV Vaccine Availability on Uptake

Small, Stephanie; Patel, Divya

doi:10.1016/j.nurpra.2011.06.005

Cited by 8 publications

(5 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Findings from our study revealed that availability of HPV vaccines at vaccination sites on all adolescents' visits is associated with higher prevalence. This result is consistent with a study done by Small (2012) [24] which evaluated the impact of HPV vaccine availability on uptake among 19- to 26-year-old female patients of Planned Parenthood of Mid and South Michigan before and after the vaccine became available at the health centre. Availability of the HPV vaccine increased vaccine uptake from 11% before clinic availability to 16% after availability.…”

Section: Discussionsupporting

confidence: 91%

Level and factors associated with uptake of Human papillomavirus infection vaccine among female adolescents in Lira District, Uganda

Kisaakye¹,

Namakula²,

Kihembo³

et al. 2018

Pan Afr Med J

View full text Add to dashboard Cite

Introduction the principal burden of human papillomavirus (HPV) infections is cervical cancer. Cervical cancer ranks as the fourth most common malignancy in women affecting 500,000 women each year with an estimated 266,000 deaths. Uganda has one of the highest cervical cancer incidence rates globally with an age-standardised incidence rate per 100,000 of 47.5. This study assessed the level and the factors associated with uptake of HPV vaccine by female adolescents in Lira district, Uganda. Methods a mixed methods approach was employed using a survey among 460 female adolescents. We collected data using an interviewer-administered questionnaire. We interviewed five key informants and conducted ten in-depth interviews. Uptake was defined as completing three doses of the vaccine as per the recommended schedule. Prevalence risk ratios were used as measures of association and were computed using modified poison regression. Content analysis was used for qualitative data. Results the mean age of the respondents was 13.97 (SD=1.24). Uptake was at 17.61% (81/460). The factors associated with uptake of HPV vaccine were: attaining ordinary level of education (aPR 1.48, 95%CI 1.11-1.97), positive attitude towards the vaccine (aPR 3.46, 95%CI 1.70-7.02), receiving vaccine doses from different vaccination sites (aPR 1.59, 95% CI 1.10-2.28) and encouragement from a health worker (aPR 1.55, 95%CI 1.15-2.11) or Village Health Team (aPR 3.47, 95%CI 1.50-8.02) to go for the vaccine. Other factors associated with uptake of HPV vaccine included; the existence of community outreaches (aPR 1.47, 95%CI 1.02-2.12), availability of vaccines at vaccination sites (aPR 4.84, 95%CI 2.90-8.08) and receiving full information about the vaccine at the vaccination site (aPR 1.90, 95%CI 1.26-2.85). Conclusion HPV vaccine uptake was low in Lira district. Efforts to improve uptake of HPV vaccine should focus on ensuring a consistent supply of vaccines at the vaccination sites, health education aimed at creating a positive attitude towards the vaccine, sensitisation of the adolescents about the vaccine and conducting community outreaches.

show abstract

Section: Discussionsupporting

confidence: 91%

Level and factors associated with uptake of Human papillomavirus infection vaccine among female adolescents in Lira District, Uganda

Kisaakye¹,

Namakula²,

Kihembo³

et al. 2018

Pan Afr Med J

View full text Add to dashboard Cite

show abstract

“…This was in agreement with the study done by Stephaine etal in 2012 whose results showed that addressing Accessibility to HPV vaccination services in uenced the increase in uptake of HPV Vaccination from 11% before vaccine availability to 16% after vaccine availability at health facilities. [24]. Also, this study demonstrated a signi cant independent association between satisfaction of adolescents with HPV Vaccination services at the health facility and uptake of the second dose of HPV Vaccine.…”

Section: Factors Associated With Uptake Of the Second Dose Of Hpv Vac...supporting

confidence: 54%

Prevalence and Factors Associated With Uptake of the Second Dose of the Human Papilloma Virus Vaccine Among Adolescent Girls in Kawempe Division, Kampala

Nakendo¹,

Busingye²,

Kakaire³

2022

Preprint

View full text Add to dashboard Cite

Introduction: Cervical cancer is a major public health problem and a leading cause of cancer related deaths among women in Uganda. Cervical cancer is caused by human papilloma virus. The ministry of health introduced HPV vaccine in the national routine immunization program which is given in two doses. Many adolescents receive HPV-1 but miss HPV-2; therefore don’t get full protection against the Human papilloma virus. This study determined the prevalence and factors associated with uptake of second dose of the human papilloma virus vaccine among adolescent girls in Kawempe division, Uganda.Methods: A cross sectional study was conducted among 550 female adolescent girls. Multi-stage random sampling was used to select the parishes and villages with the homes of the parents of the girls. Data were collected using an interviewer administered questionnaire. Uptake of the HPV-2 Vaccine was determined. Bivariate and multivariate analysis was conducted to determine factors independently associated with uptake of the second dose of HPV Vaccine.Results: The Uptake of the second dose of HPV Vaccine was 44.6% (245/550). The factors associated with HPV-2 Vaccine uptake were: knowledge about HPV vaccination services (AOR = 1.88, 95% CI = 1.26–2.79, P = 0.002), Satisfaction of adolescent girls about the HPV vaccination services (AOR = 1.96, 95% CI = 1.10–3.49, P = 0.022), access to HPV services by participants (AOR = 1.63, 95% CI = 1.13–2.34, P = 0.009), secondary level of education of adolescent girls (AOR = 1.78, 95% CI = 1.15–2.75, P = 0.010), the level of education of the participants’ father being Secondary (AOR = 0.36, 95% CI = 0.19–0.69, P = 0.002) and being Tertiary (AOR = 0.38, CI = 0.19–0.74, P = 0.005.Conclusion: The uptake of the second dose of the HPV Vaccine of 44.6% is still short of the Uganda’s national multi-year plan target of achieving HPV Vaccination coverage of 85%. Efforts to improve the uptake of second dose of the HPV Vaccine should focus on strengthening the school outreach programs so that both the first and second HPV vaccine doses are given at school.

show abstract

“…Our educational modules were useful in addressing the baseline inadequacies in clinician knowledge which may be contributing to their reported concerns about underutilization of genetic services among their clients (Carroll et al 2009;Bellcross et al 2011;Klitzman et al 2013;Salm et al 2014). The acceptance and impact of the educational modules on clinicians' perceptions of genetic knowledge reinforce the idea that working directly with clinicians who see underserved populations can provide added benefit (Small and Patel 2012). Our educational modules clarified many misconceptions, including those related to the affordability and accessibility of genetic services.…”

Section: Discussionmentioning

confidence: 75%

Evaluating and improving the implementation of a community-based hereditary cancer screening program

et al. 2018

View full text Add to dashboard Cite

Healthcare disparities exist in the provision of cancer genetic services including genetic counseling and testing related to BRCA1/2 mutations. To address this in a community health setting a screening tool was created to identify high-risk women. This study evaluates the implementation of the tool and identifies opportunities for improved cancer genetic screening, including regular clinician education. A mixed-method approach was used to evaluate clinician utilization of the screening tool at Planned Parenthood affiliates. Novel surveys that evaluated acceptance and implementation were administered to clinicians (n = 14) and semi-structured interviews (n = 6) were used to explore clinicians' perspectives and identify gaps in its utilization. Educational modules that addressed gaps were developed, implemented, and evaluated using a post-education survey (n = 8). Clinicians reported confidence in administering and interpreting the screening tool, but reported less confidence in their knowledge of cancer genetics and ability to connect clients with genetic counseling and testing (p = .003). Educational modules resulted in significant gains in clinician knowledge on genetic topics (p < .05) and increased self-reported confidence in connecting clients with genetic services. The modules reinforced the belief that genetic testing is beneficial for patients at increased risk (p = .001) and is important to inform subsequent medical management (p = .027). While building community clinicians' capacity to connect clients with genetic services is crucial, it is challenged by knowledge and confidence gaps in discussions of genetic services with clients. Consistent genetic-focused education with non-genetic clinicians can improve confidence and knowledge, enabling a more effective screening program in community health settings.

show abstract

Impact of HPV Vaccine Availability on Uptake

Cited by 8 publications

References 18 publications

Level and factors associated with uptake of Human papillomavirus infection vaccine among female adolescents in Lira District, Uganda

Level and factors associated with uptake of Human papillomavirus infection vaccine among female adolescents in Lira District, Uganda

Prevalence and Factors Associated With Uptake of the Second Dose of the Human Papilloma Virus Vaccine Among Adolescent Girls in Kawempe Division, Kampala

Evaluating and improving the implementation of a community-based hereditary cancer screening program

Contact Info

Product

Resources

About